Interact to see
Advertisement
Advertisement
MAV vs NZF
MAV vs NZF Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
MAV vs. NZF commentary
Jul 05, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAV is a Hold and NZF is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
NZF has more net assets: 2.4B vs. MAV (204M). NZF has a higher annual dividend yield than MAV: NZF (2.582) vs MAV (1.280). MAV was incepted earlier than NZF: MAV (22 years) vs NZF (24 years). NZF (1.60) has a lower expense ratio than MAV (1.82). MAV has a higher turnover NZF (16.00) vs NZF (16.00).
| MAV | NZF | MAV / NZF | |
| Gain YTD | 1.280 | 2.582 | 50% |
| Net Assets | 204M | 2.4B | 8% |
| Total Expense Ratio | 1.82 | 1.60 | 114% |
| Turnover | 33.00 | 16.00 | 206% |
| Yield | 4.58 | 5.58 | 82% |
| Fund Existence | 22 years | 24 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| MAV | NZF | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 64% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 72% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 75% |
| TrendMonth ODDS (%) | 2 days ago 75% | 2 days ago 74% |
| Advances ODDS (%) | 3 days ago 80% | 3 days ago 76% |
| Declines ODDS (%) | 17 days ago 80% | 19 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 66% | 2 days ago 65% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 74% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TRFM | 43.40 | 0.60 | +1.41% |
| AAM Transformers ETF | |||
| USSE | 32.36 | 0.42 | +1.31% |
| Segall Bryant & Hamill Select Equity ETF | |||
| ETW | 8.70 | 0.05 | +0.58% |
| Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
| CNCR | 9.02 | N/A | N/A |
| Range Cancer Therapeutics ETF | |||
| LIAK | 194.65 | N/A | N/A |
| LifeX 2054 Infl-Prt Longevity Inc ETF | |||